Fitness Ozempic, Wegovy: India’s cheap weight-loss drugs could reshape global obesity fight Published 3 months ago on March 18, 2026 By News24x7 Share Tweet With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market. Related Topics: Up Next ‘Club vibes without the hangover’: The twenty-somethings going out – in the gym Don't Miss Jersey woman felt ‘responsibility’ to share diabetes diagnosis Continue Reading Latest Travel39 minutes ago Kiwi travellers have moved on from COVID – and found new worries World47 minutes ago Sweden man jailed for four years for coercing wife into sex with 120 men World49 minutes ago FBI thwarted plot targeting White House UFC event, Patel says World51 minutes ago Hungary’s MPs block return of Orbán, limiting PM’s rule to eight years Travel1 hour ago Dads To Travel Free With Wightlink This Father’s Day Entertainment1 hour ago Cate Blanchett to become visiting University of Oxford professor Bussiness1 hour ago SpaceX buys AI coding start-up Cursor for $60bn days after IPO Tech1 hour ago Five big questions about the UK’s under-16s social media ban Travel1 hour ago Rachel O’Reilly steps down from travel company Travel2 hours ago Latest amid major travel disruption across Stroud